Literature DB >> 24078191

Human immunodeficiency virus and hepatitis C virus coinfection in Nepal.

Satish Prasad Barnawal1, Surya Raj Niraula, Anand Kumar Agrahari, Nikesh Bista, Nilambar Jha, Paras Kumar Pokharel.   

Abstract

OBJECTIVES: The study aimed at finding prevalence, mode of transmission, and pattern of CD4 cell count among hepatitis C virus (HCV) coinfected human immunodeficiency virus (HIV)-positive individuals in Nepal.
METHODS: This was a descriptive cross-sectional study carried out in three Volunteer Counseling and Testing clinics, one from Dharan and two from Kathmandu, Nepal. Three hundred and thirteen individuals were recruited.
RESULTS: Forty-two percent of HIV-infected persons had HCV coinfection. Significant associations with HIV and HCV coinfection were male gender (p <0.001) and injection drug use (IDU) (p <0.001). The mean CD4 cell count was significantly lower in HCV coinfected individuals, compared to those without coinfection, after 1.5 years (p =0.017), 2 years (p =0.0457), 3 years (p =0.011), and 3.5 years (p <0.001) of antiretroviral therapy.
CONCLUSION: HCV coinfection was common in HIV-infected individuals in Nepal and was associated with male gender, IDU, and lower CD4 counts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078191     DOI: 10.1007/s12664-013-0407-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  38 in total

Review 1.  Care of patients with hepatitis C and HIV co-infection.

Authors:  Vincent Soriano; Massimo Puoti; Mark Sulkowski; Stefan Mauss; Patrice Cacoub; Antonietta Cargnel; Douglas Dieterich; Angelos Hatzakis; Jurgen Rockstroh
Journal:  AIDS       Date:  2004-01-02       Impact factor: 4.177

2.  Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

Authors:  Shruti H Mehta; Gregory M Lucas; Lisa B Mirel; Michael Torbenson; Yvonne Higgins; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

3.  Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China.

Authors:  Han-Zhu Qian; Sten H Vermund; Richard A Kaslow; Christopher S Coffey; Eric Chamot; Zhongmin Yang; Xiaochun Qiao; Yuliang Zhang; Xiaoming Shi; Yan Jiang; Yiming Shao; Ning Wang
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177

4.  Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.

Authors:  Paula Braitstein; Amy Justice; David R Bangsberg; Benita Yip; Victoria Alfonso; Martin T Schechter; Robert S Hogg; Julio S G Montaner
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

5.  Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

Authors:  Annie Luetkemeyer; C Bradley Hare; John Stansell; Phyllis C Tien; Edwin Charlesbois; Paula Lum; Diane Havlir; Marion Peters
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

Review 6.  HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Authors:  Holly Hagan; Hanne Thiede; Don C Des Jarlais
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

7.  Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.

Authors:  Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Torsten B Neilands; Colleen F Kelley; Peter W Hunt; Rebecca Hoh; Jeffrey M Linnen; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

8.  Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas.

Authors:  Marilú Barbieri Victoria; Flamir da Silva Victoria; Kátia Luz Torres; Simone Kashima; Dimas Tadeu Covas; Adriana Malheiro
Journal:  Braz J Infect Dis       Date:  2010 Mar-Apr       Impact factor: 1.949

9.  Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Authors:  Patrick S Sullivan; Debra L Hanson; Eyasu H Teshale; Linda L Wotring; John T Brooks
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

Review 10.  Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C.

Authors:  Paula Braitstein; Anita Palepu; Douglas Dieterich; Yves Benhamou; Julio S G Montaner
Journal:  AIDS       Date:  2004-11-19       Impact factor: 4.177

View more
  1 in total

Review 1.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.